OsseoLabs: Advancing Surgical Solutions through AI and 3D Printing Technology in the US Market

×

Fehlermeldung

  • Notice: Undefined property: stdClass::$ds_changed in eval() (Zeile 16 von /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (Zeile 20 von /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (Zeile 20 von /var/www/7/modules/php/php.module(80) : eval()'d code).

Having already established partnerships with over 20 hospitals in Thailand, OsseoLabs is poised to meet the growing demand for specialized procedures.

Metadata
Provider: 
NewsfileNewsfile
Retrieved on: 
Montag, April 15, 2024
Information
Tags: 
FDA, Mandible, Dentistry, Hospital, Phramongkutklao Hospital, Heart, Osseointegration, TPMS, Chulalongkorn University, Rajavithi Hospital, Ramathibodi Hospital, Dental school, Faculty
Geotags: 
BANGKOK, THAILAND, US
Zusammenfassung
Key Points: 
  • Having already established partnerships with over 20 hospitals in Thailand, OsseoLabs is poised to meet the growing demand for specialized procedures.
  • Specializing in maxillofacial and orthopedic surgeries, OsseoLabs is leading a revolution with personalized surgical solutions tailored to individual patient needs.
  • They are also backed by close to $2 million in venture funding; OsseoLabs is now looking to roll out its surgical procedures internationally.
  • At the heart of the technology is their patented TPMS technology, which enables the creation of unique, customizable implants designed to promote optimal osseointegration.


Bangkok, Thailand--(Newsfile Corp. - April 15, 2024) - OsseoLabs, a pioneering medical device startup specializing in advanced reconstructive procedures utilizing AI-powered technology and 3D printing, has recently announced its expansion into the Global market in 2024. Having already established partnerships with over 20 hospitals in Thailand, OsseoLabs is poised to meet the growing demand for specialized procedures.

Specializing in maxillofacial and orthopedic surgeries, OsseoLabs is leading a revolution with personalized surgical solutions tailored to individual patient needs. They've established several notable partnerships in Thailand, including the Faculty of Dentistry at Chulalongkorn University, the Department of Orthopedics, Phramongkutklao Hospital, Rajavithi Hospital, and Ramathibodi Hospital. They are also backed by close to $2 million in venture funding; OsseoLabs is now looking to roll out its surgical procedures internationally. Specifically, their focus extends to procedures like mandibular reconstruction, talus reconstruction, spinal reconstruction, and those that address prevalent medical issues such as cleft palates.

At the heart of the technology is their patented TPMS technology, which enables the creation of unique, customizable implants designed to promote optimal osseointegration. These implants are distinguished by their customized internal porous design features, including shape, size, thickness, and a proprietary porous structure. OsseoLabs' implants boast significantly lower rejection rates compared to conventional methods, ensuring better patient outcomes.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/10129/205053_6684ad8c24047951_001.jpg

(photo credit: OsseoLabs)

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10129/205053_6684ad8c24047951_001full.jpg

Through a series A funding round, OsseoLabs is actively pursuing FDA approval for the US and European markets, aiming to broaden its clientele and impact. Additionally, OsseoLabs is open to collaborating with executives and licensing its advanced medical technology to further expand its reach.

In saturating the Thai medical market with their technology, OsseoLabs has been growing personalized medical devices and has successfully completed over 80 clinical cases, ranging from mandible and orthognathic surgeries to talus reconstruction. These procedures have demonstrated effectiveness with surgical solutions and implants that seamlessly integrate with natural bone growth, leading to enhanced durability and accelerated patient recovery.

While OsseoLabs' immediate objectives of global expansion are evident, its larger mission is to establish pioneering global healthcare standards through a precise and highly patient-centric approach seldom seen in the field of medical devices.

About:

OsseoLabs was founded by Dr. Vikram Ahuja and Assoc. Prof. Dr. Patcharapit Promoppatum is a pioneering medical device startup specializing in advanced reconstructive procedures utilizing AI-powered technology and 3D printing. Recently expanding into the US market in 2024, with established partnerships in over 20 US hospitals, OsseoLabs is positioned to meet the growing demand for specialized procedures, particularly in maxillofacial and orthopedic surgeries. With a focus on personalized surgical solutions, OsseoLabs' patented TPMS technology enables the creation of unique implants designed for optimal osseointegration, boasting significantly lower rejection rates compared to conventional methods. Actively pursuing FDA approval for the US and European markets through a series A investment round, OsseoLabs aims to broaden its impact globally while adhering to a highly patient-centric approach, setting new standards in medical device innovation.

Company Name: OsseoLabs

Contact Person: Vikram Ahuja, Patcharapit Promoppatum

Get in touch: Vikram @osseolabs.com

Website Link: https://osseolabs.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/205053

Copyright: 
(c) Copyright Newsfile Corp. 2024